REVIEW
Published on 21 Aug 2024
An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies
doi 10.3389/fimmu.2024.1351584
- 1,218 views
- 2 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume II
Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume II
21k
Total downloads
69k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 05 Jul 2024
Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy
doi 10.3389/fimmu.2024.1352632
- 2,029 views
- 3 citations
ORIGINAL RESEARCH
Published on 16 Apr 2024
The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy
doi 10.3389/fimmu.2024.1293723
- 1,749 views
REVIEW
Published on 21 Mar 2024
Circulating T cells: a promising biomarker of anti-PD-(L)1 therapy
doi 10.3389/fimmu.2024.1371559
- 2,088 views
- 2 citations
ORIGINAL RESEARCH
Published on 15 Mar 2024
Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies
doi 10.3389/fimmu.2024.1352615
- 5,320 views
- 12 citations
REVIEW
Published on 08 Mar 2024
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
doi 10.3389/fimmu.2024.1368749
- 5,391 views
- 15 citations
ORIGINAL RESEARCH
Published on 22 Feb 2024
Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers
doi 10.3389/fimmu.2024.1285049
- 2,771 views
- 7 citations
REVIEW
Published on 31 Oct 2023
Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status
doi 10.3389/fimmu.2023.1297175
- 13,540 views
- 11 citations
ORIGINAL RESEARCH
Published on 19 Sep 2023
Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands
doi 10.3389/fimmu.2023.1151748
- 5,155 views
- 6 citations
ORIGINAL RESEARCH
Published on 03 Jul 2023
Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
doi 10.3389/fimmu.2023.1196829
- 2,840 views
- 8 citations
ORIGINAL RESEARCH
Published on 28 Jun 2023
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance
doi 10.3389/fimmu.2023.1161869
- 4,506 views
- 8 citations
ORIGINAL RESEARCH
Published on 27 Jun 2023
Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma
doi 10.3389/fimmu.2023.1173524
- 2,168 views
- 5 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore